vs

Side-by-side financial comparison of LandBridge Co LLC (LB) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

LandBridge Co LLC is the larger business by last-quarter revenue ($56.8M vs $32.6M, roughly 1.7× RxSight, Inc.). LandBridge Co LLC runs the higher net margin — 14.2% vs -28.1%, a 42.3% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs -18.9%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $-2.3M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs 5.1%).

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

LB vs RXST — Head-to-Head

Bigger by revenue
LB
LB
1.7× larger
LB
$56.8M
$32.6M
RXST
Growing faster (revenue YoY)
LB
LB
+74.5% gap
LB
55.6%
-18.9%
RXST
Higher net margin
LB
LB
42.3% more per $
LB
14.2%
-28.1%
RXST
More free cash flow
LB
LB
$124.3M more FCF
LB
$122.0M
$-2.3M
RXST
Faster 2-yr revenue CAGR
LB
LB
Annualised
LB
72.8%
5.1%
RXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LB
LB
RXST
RXST
Revenue
$56.8M
$32.6M
Net Profit
$8.1M
$-9.2M
Gross Margin
77.5%
Operating Margin
60.0%
-34.8%
Net Margin
14.2%
-28.1%
Revenue YoY
55.6%
-18.9%
Net Profit YoY
-83.7%
-54.1%
EPS (diluted)
$0.24
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LB
LB
RXST
RXST
Q4 25
$56.8M
$32.6M
Q3 25
$50.8M
$30.3M
Q2 25
$47.5M
$33.6M
Q1 25
$44.0M
$37.9M
Q4 24
$36.5M
$40.2M
Q3 24
$28.5M
$35.3M
Q2 24
$26.0M
$34.9M
Q1 24
$19.0M
$29.5M
Net Profit
LB
LB
RXST
RXST
Q4 25
$8.1M
$-9.2M
Q3 25
$8.1M
$-9.8M
Q2 25
$7.5M
$-11.8M
Q1 25
$6.5M
$-8.2M
Q4 24
$49.3M
$-5.9M
Q3 24
$2.7M
$-6.3M
Q2 24
$-57.7M
$-6.1M
Q1 24
$10.8M
$-9.1M
Gross Margin
LB
LB
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
LB
LB
RXST
RXST
Q4 25
60.0%
-34.8%
Q3 25
60.8%
-40.1%
Q2 25
60.0%
-41.6%
Q1 25
57.0%
-28.2%
Q4 24
49.4%
-21.5%
Q3 24
11.2%
-26.1%
Q2 24
-197.4%
-23.9%
Q1 24
71.1%
-36.2%
Net Margin
LB
LB
RXST
RXST
Q4 25
14.2%
-28.1%
Q3 25
15.9%
-32.4%
Q2 25
15.8%
-35.0%
Q1 25
14.7%
-21.6%
Q4 24
135.2%
-14.8%
Q3 24
9.3%
-17.9%
Q2 24
-222.1%
-17.4%
Q1 24
56.7%
-30.8%
EPS (diluted)
LB
LB
RXST
RXST
Q4 25
$0.24
$-0.22
Q3 25
$0.26
$-0.24
Q2 25
$0.24
$-0.29
Q1 25
$0.20
$-0.20
Q4 24
$-0.14
Q3 24
$-0.04
$-0.16
Q2 24
$-0.16
Q1 24
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LB
LB
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$30.7M
$228.1M
Total DebtLower is stronger
$570.7M
Stockholders' EquityBook value
$340.3M
$275.7M
Total Assets
$1.4B
$311.8M
Debt / EquityLower = less leverage
1.68×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LB
LB
RXST
RXST
Q4 25
$30.7M
$228.1M
Q3 25
$28.3M
$227.5M
Q2 25
$20.3M
$227.5M
Q1 25
$14.9M
$229.3M
Q4 24
$37.0M
$237.2M
Q3 24
$14.4M
$237.1M
Q2 24
$24.6M
$233.3M
Q1 24
$125.4M
Total Debt
LB
LB
RXST
RXST
Q4 25
$570.7M
Q3 25
$366.1M
Q2 25
$370.9M
Q1 25
$375.5M
Q4 24
$385.5M
Q3 24
$242.4M
Q2 24
$360.8M
Q1 24
Stockholders' Equity
LB
LB
RXST
RXST
Q4 25
$340.3M
$275.7M
Q3 25
$272.0M
$276.0M
Q2 25
$266.4M
$278.0M
Q1 25
$217.0M
$279.3M
Q4 24
$211.8M
$281.2M
Q3 24
$97.2M
$277.3M
Q2 24
$296.4M
$275.2M
Q1 24
$162.3M
$163.9M
Total Assets
LB
LB
RXST
RXST
Q4 25
$1.4B
$311.8M
Q3 25
$1.1B
$308.5M
Q2 25
$1.1B
$309.0M
Q1 25
$1.0B
$313.0M
Q4 24
$1.0B
$318.6M
Q3 24
$689.9M
$310.5M
Q2 24
$710.5M
$305.5M
Q1 24
$183.2M
Debt / Equity
LB
LB
RXST
RXST
Q4 25
1.68×
Q3 25
1.35×
Q2 25
1.39×
Q1 25
1.73×
Q4 24
1.82×
Q3 24
2.49×
Q2 24
1.22×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LB
LB
RXST
RXST
Operating Cash FlowLast quarter
$126.3M
$-1.1M
Free Cash FlowOCF − Capex
$122.0M
$-2.3M
FCF MarginFCF / Revenue
214.9%
-6.9%
Capex IntensityCapex / Revenue
7.5%
3.5%
Cash ConversionOCF / Net Profit
15.68×
TTM Free Cash FlowTrailing 4 quarters
$207.7M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LB
LB
RXST
RXST
Q4 25
$126.3M
$-1.1M
Q3 25
$34.9M
$-1.2M
Q2 25
$37.3M
$-4.4M
Q1 25
$15.9M
$-8.8M
Q4 24
$67.6M
$-4.3M
Q3 24
$7.5M
$650.0K
Q2 24
$16.0M
$-4.0M
Q1 24
$17.2M
$-9.3M
Free Cash Flow
LB
LB
RXST
RXST
Q4 25
$122.0M
$-2.3M
Q3 25
$33.7M
$-1.8M
Q2 25
$36.1M
$-5.9M
Q1 25
$15.8M
$-9.4M
Q4 24
$66.7M
$-5.1M
Q3 24
$7.1M
$-453.0K
Q2 24
$15.7M
$-5.5M
Q1 24
$17.1M
$-11.3M
FCF Margin
LB
LB
RXST
RXST
Q4 25
214.9%
-6.9%
Q3 25
66.3%
-5.8%
Q2 25
75.9%
-17.6%
Q1 25
36.0%
-24.8%
Q4 24
182.6%
-12.7%
Q3 24
25.1%
-1.3%
Q2 24
60.4%
-15.9%
Q1 24
90.1%
-38.2%
Capex Intensity
LB
LB
RXST
RXST
Q4 25
7.5%
3.5%
Q3 25
2.3%
1.9%
Q2 25
2.6%
4.6%
Q1 25
0.2%
1.5%
Q4 24
2.7%
2.1%
Q3 24
1.1%
3.1%
Q2 24
1.4%
4.4%
Q1 24
0.5%
6.7%
Cash Conversion
LB
LB
RXST
RXST
Q4 25
15.68×
Q3 25
4.31×
Q2 25
4.98×
Q1 25
2.46×
Q4 24
1.37×
Q3 24
2.80×
Q2 24
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LB
LB

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons